The Netherlands: Forbion issues US$110m European-focused SPAC on Nasdaq

By
Nick Herbert
-
Manhattan, New York. December 23, 2020. People walking in front of Nasdaq market site located at 4 Times Square.

European dedicated life sciences VC, Forbion, has listed Forbion European Acquisition Corporation (FEAC), a US$110m blank cheque company incorporated in the Cayman Islands, on Nasdaq via joint books UBS and Kempen & Co. The upsized IPO consists of 11 million units at a price of US$10 per unit. There is an over-allotment option of up…

You must be a HMI Subscriber to view this content.

Subscribe Now »

RELATED ARTICLESMORE FROM AUTHOR